I really don't want to be a doctor

Chapter 214 Clinical Examples
"There really are!" Zhu Xianqing looked at Jing Xiaoran's article and said, "I never noticed this mesenchymal stem cell before!"

In fact, most people's attention is focused on exposing Professor Piero Anversa, and almost no one has noticed the mesenchymal stem cells mentioned at the end of the article.

When Jing Xiaoran wrote about mesenchymal stem cells, he also thought of it by accident; after all, there has been such a big scandal in the academic world, except for the false cardiac stem cell field, there is always a little hope for everyone, isn't it?
This mesenchyme just fits this point, and it has been confirmed by scholars in previous lives that it can indeed replace the status of cardiac stem cells in Professor Piero Anversa's thesis to treat heart diseases.

"So I feel that in Mr. Jing, I can see the direction of future scientific research." Jeffrey looked at Jing Xiaoran with fiery eyes.

He seemed to have forgotten Jing Xiaoran's age, his eyes were full of respect for Jing Xiaoran.

"Don't be so exaggerated." Jing Xiaoran smiled, "Actually, mesenchymal stem cells have been used to treat heart disease, and there have been several examples in the scientific community."

"Is there any example of mesenchymal stem cells treating heart disease?" Jeffrey was a little surprised. He has been working in this field for these years. Although he has not made any major discoveries, he still has a good understanding of the cutting-edge knowledge in the field of stem cells.

But even so, Jeffrey has never heard of any examples of mesenchymal stem cells treating heart disease.

Jing Xiaoran nodded: "As far as I know, there are currently three cases in the world."

"There are still three cases?!"

Jeffrey was immediately interested.

"In the first case, Dr. David M. Clifford of the Stem Cell Research Laboratory of the University of Oxford, England, and his colleagues conducted a Meta-analysis on 2009 clinical trials of stem cell myocardial infarction subjects conducted in 2011 countries between 17 and 1, summarizing The results showed that this stem cell treatment significantly improved left ventricular function and reduced left ventricular end-systolic and end-diastolic volumes, while reducing infarct size and heart wall motion."

"The second case, in 2010, 20 cases of autologous stem cell transplantation in Harvard Medical School for myocardial infarction, the results proved to be helpful for heart repair; another 60 cases of ST-segment elevation myocardial infarction after autologous stem cell transplantation, electrocardiogram ST-segment elevation, Enhance the systolic function of the left ventricle and improve the ejection fraction of the heart."

"In 2011, 24 patients with myocardial infarction at Waseda University in Japan underwent stem cell transplantation. After 6 months of follow-up, the cardiac function was significantly improved, the left ventricular ejection fraction increased, and the right ventricular end diastolic diameter decreased."

These three cases were screened by Jing Xiaoran around the world, all of which are the application of mesenchymal stem cells in the field of heart disease treatment.

However, these three items are only clinical experiments, and there is no theoretical support for basic experiments, so the current argument lacks scientific theoretical knowledge.

If you want to truly popularize a treatment method, you need a theoretical basis that can withstand scrutiny, otherwise it is just empiricism!
"There are so many clinical trials, why haven't there been reports?" Jeffrey wondered.

The field of mesenchymal stem cells should also be a research hotspot!It is a bit strange that there is no announcement for such a large clinic.

"Mine should be suppressed by Professor Piero Anversa's field of cardiac stem cells. Everyone is paying attention to cardiac stem cells. Who wants mesenchymal stem cells?"

……

On the surface, it was a job fair, but unknowingly, it turned into an academic seminar for the three of Jing Xiaoran.

This made the people who were waiting for the interview results outside the office very anxious, and the foreign boy took too long to go in for the interview.

Many people are scratching their heads and waiting for the results of the interview. Although Shenzhou Biopharmaceutical Laboratory is a new laboratory, the conditions and equipment are the most advanced, and the salary and treatment are about 20% higher than those in the industry.

At this time, in the recruiting laboratory, Jeffrey was holding the journal and asking Jing Xiaoran about the issue of mesenchymal stem cells.

"Mr. Jing, now that some people have confirmed the feasibility of mesenchymal stem cells in treating heart disease, how do you think this topic should be done? How to explore the theoretical basis contained in this question?" Jeffrey said .

"Well." Jing Xiaoran paused, "I'm sorry, I just brought up this topic, but I'm not interested in doing it, I just wrote it down."

"What?" Zhu Xianqing cast a glance at Jing Xiaoran from the corner of his eye, "If this mesenchymal stem cell can really work, it must be another remarkable achievement!"

Dental pulp mesenchymal stem cells: Compared with stem cells from other sources of human tissue, dental pulp stem cells are the most ideal "seed cells", with low immunogenicity, family use without matching, differentiation and regeneration capabilities are other sources of mesenchyme Stem cells are more than three times more powerful and many other advantages, and will definitely exert greater medical value in the future.

When Jing Xiaoran heard this, he just grinned: "Mr. Zhu, it is equivalent to this stem cell. I think the project that our laboratory is developing is much more powerful than this!"

Zhu Xianqing immediately understood what Jing Xiaoran meant, the immune check inhibitor, which changed the history of cancer treatment and extended the survival period of countless cancer patients!
"Immune checkpoint inhibitors" are definitely higher-end than "mesenchymal stem cells"!

Jeffrey didn't expect that Jing Xiaoran didn't plan to make mesenchymal stem cells, but he immediately thought of something, and laughed quickly: "Such a good project, it can't be wasted! That's why I want to come to Shenzhou Laboratory! "

Listening to Jeffrey's sophistry, Jing Xiaoran couldn't help being happy. It seems that this foreign guy really wants to come to Shenzhou Laboratory.

According to his conditions, it is indeed qualified!

But Jing Xiaoran can't let foreigners enter the laboratory so easily. After all, there will be many world-class scientific research projects here in the future, and many things cannot be easily shown to foreigners, for fear that they will leak the secrets or pass it on to the outside world!
Although science has no borders, scientists have borders; Jing Xiaoran doesn't want what he has worked so hard to make for others.

"Jeffrey, I can let you enter the Shenzhou Laboratory." Jing Xiaoran said, "But I have three conditions."

Jeffrey's eyes lit up: "Mr. Jing, tell me."

"First, we need to sign a non-disclosure agreement and a competition agreement."

"I understand the confidentiality agreement." Jeffrey said, "But what is a non-compete agreement?"

When entering the laboratory research group, almost everyone needs to sign a non-disclosure agreement in order to prevent the exposure of experimental data.

"Competition agreement, if you resign now, you will not be able to work in a company or laboratory in the same industry within three years!"

"Okay! No problem!" Jeffrey nodded without hesitation. "What about the second and third?"

"Second, in our Shenzhou laboratory, you can only start from the smallest researcher."

(End of this chapter)